Clinicopathologic characteristics of synchronous primary thyroid cancer detected by initial staging 18F-FDG PET-CT examination in patients with underlying malignancy

Thyroid

Volumn 23, Issue 11, 2013, Pages 1431-1436

  Kim, Bo Hyun ^a,e   Lee, Chang Hun ^b   Kim, Seong Jang ^c   Jeon, Yun Kyung ^a   Kim, Sang Soo ^a   Kim, Yong Ki ^d   Kim, In Ju ^a,e  

^a Departments of Internal Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Pusan National University School of Medicine   (South Korea)

^d Kim Yong Ki Internal Medicine Clinic   (South Korea)

^e Biomedical Research Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COLON CANCER; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CYTOPATHOLOGY; DRUG UPTAKE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE METASTASIS; MALE; MULTIPLE CANCER; OVARY CANCER; PET SCANNER; PREOPERATIVE EVALUATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CANCER; STOMACH CANCER; SYNCHRONOUS THYROID CANCER; THYMUS CANCER; THYROID CANCER; THYROID CARCINOMA; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84882749154     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0546     Document Type: Article

References (20)

1. Koide N, Yazawa K, Koike S, Adachi W, Amano J 1997 Oesophageal cancer associated with other primary cancers. A study of 31 patients. J Gastroenterol Hepatol 12:690-694. (Pubitemid 27504889)
2. Naomoto Y, Haisa M, Yamatsuji T, Shirakawa Y, Muramatsu T, Isozaki H, Kamikawa Y, Tanaka N 1999 Multiple primary cancers of the esophagus and thyroid gland. Jpn J Clin Oncol 29:349-352.
3. King DL, Stack BC Jr, Spring PM, Walker R, Bodenner D 2007 Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg 137:400-404. (Pubitemid 47320854)
4. Boeckmann J, Bartel T, Siegel E, Bodenner D, Stack BC Jr 2012 Can the pathology of a thyroid nodule be determined by positron emission tomography uptake Otolaryngol Head Neck Surg 146:906-912.
5. Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chung JH, Lee KH, Kim BT 2006 Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization. J Nucl Med 47:609-615. (Pubitemid 46772890)
6. Soelberg KK, Bonnema SJ, Brix TH, Hegedü s L 2012 Risk of malignancy in thyroid incidentalomas detected by 18Ffluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 22:918-925.
7. Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, Valente G, Marzullo P, Baldelli R, Appetecchia M, Isidoro C, Aimaretti G 2011 Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf ) 75:528-534.
8. Kim BH, Na MA, Kim IJ, Kim SJ, Kim YK 2010 Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med 24:721-728.
9. Luciani A, Balducci L 2004 Multiple primary malignancies. Semin Oncol 31:264-273. (Pubitemid 38481244)
10. Haberkorn U, Ziegler SI, Oberdorfer F, Trojan H, Haag D, Peschke P, Berger MR, Altmann A, van Kaick G 1994 FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol 21:827-834. (Pubitemid 24263576)
11. Wang W, Larson SM, Fazzari M 2000 Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85:1107-1113. (Pubitemid 32269357)
12. Van den Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen M, Van Damme B, Delaere P, Bouillon R 2002 Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 87:1517-1520. (Pubitemid 34615231)
13. Schönberger J, Rü schoff J, Grimm D, Marienhagen J, Rümmele P, Meyringer R, Kossmehl P, Hofstaedter F, Eilles C 2002 Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an mmunohistochemical study. Thyroid 12:747-754.
14. Sandeep TC, Strachan MW, Reynolds RM, Brewster DH, Scélo G, Pukkala E, Hemminki K, Anderson A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P 2006 Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab 91:1819-1825.
15. Tanaka H, Tsukuma H, Koyama H, Kinoshita Y, Kinoshita N, Kinoshita N, Oshima A 2001 Second primary cancers following breast cancer in the Japanese female population. Jpn J Cancer Res 92:1-8. (Pubitemid 32175471)
16. Omü r O, Ozcan Z, Yazici B, Akgü n A, Oral A, Ozkiliç H 2008 Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome. Endocr J 55:365-372. (Pubitemid 351670964)
17. Kaida H, Hiromatsu Y, Kurata S, Kawahara A, Hattori S, Taira T, Kobayashi M, Uchida M, Yamada K, Mihashi H, Umeno H, Kage M, Nakashima T, Hayabuchi N, Ishibashi M 2011 Relationship between clinicopathological factors and fluorine-18-fluorodeoxyglucose uptake in patients with papillary thyroid cancer. Nucl Med Commun 32:690-698.
18. Park YW, Do IG, Park YK 2006 Expression of the GLUT1 glucose transporter, p63 and p53 in thyroid carcinomas. Pathol Res Pract 202:759-765. (Pubitemid 44575893)
19. Grabellus F, Nagarajah J, Bockisch A, Schmid KW, Sheu SY 2012 Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clin Nucl Med 37:121-127.
20. Baek SK, Kwon SY, Woo JS, Jung KY, Kim GI 2004 Prognostic Significance of COX-2 and VEGF-C Expression in Thyroid Papillary Carcinoma. Korean J Otolaryngol Head Neck Surg 47:1273-1277.